What Kind of Melatonin Is Best?

Walk into any pharmacy and you'll find melatonin in at least half a dozen forms — tablets, gummies, capsules, liquid drops, sublingual sprays, and patches. They all carry the same active ingredient, but a systematic review of 22 pharmacokinetic studies found that oral melatonin bioavailability ranges from just 9–33%. The form you choose determines how much of what's on the label actually reaches your bloodstream — and that gap is large enough to explain why the same supplement produces wildly different results for different people.

Table of Contents

1. Why the Form of Melatonin Matters More Than the Dose
2. Standard Tablets and Capsules: The Most Common, Least Efficient Form
3. Gummies: Convenient But Inconsistent
4. Sublingual Forms: Faster Absorption, Better Bioavailability
5. Transdermal Patches: A Niche Use Case
6. Liposomal Liquid: The Bioavailability Leader
7. BioAbsorb Liposomal Melatonin — Precision Dosing for Real Results
8. How to Choose the Right Melatonin Form for You
9. Frequently Asked Questions
10. Conclusion

1. Why the Form of Melatonin Matters More Than the Dose

Melatonin is unusual among supplements in that its oral bioavailability is both low and highly variable. A 2015 systematic review covering 22 clinical studies found that bioavailability from oral tablets averages approximately 15%, with a range of 9–33% across individuals. That variability isn't random — it's driven by a phenomenon called first-pass hepatic metabolism, where melatonin is extensively broken down by the liver enzyme CYP1A2 before it ever enters systemic circulation.

What this means in practice is that two people taking the same 5mg tablet may end up with very different blood melatonin concentrations. A New England Journal of Medicine study showed that individual oral bioavailability ranged from 10% to 56% — a more than 5-fold difference. One person absorbs 0.5mg from a 5mg tablet; another absorbs 2.8mg from the same tablet. This variability explains why melatonin "doesn't work" for some people who are actually under-absorbing, while others experience morning grogginess because they're absorbing far more than intended.

The form of melatonin you choose determines how much of the first-pass problem you face. Forms that bypass the digestive tract — sublingual, transdermal, and liposomal — each use a different mechanism to improve on the tablet baseline. StatPearls notes that effective dosing for melatonin is not well-defined because bioavailability varies so much by formulation — making form selection the most important variable in the equation.

2. Standard Tablets and Capsules: The Most Common, Least Efficient Form

Standard oral tablets and capsules account for the vast majority of melatonin sold globally, and their popularity is easy to explain — they're inexpensive, familiar, and available everywhere. What's harder to see at the pharmacy shelf is the pharmacokinetic reality: a randomized crossover study in 12 healthy volunteers confirmed that both 2mg and 4mg oral tablet doses showed an absolute bioavailability of approximately 15%, with the remainder lost to hepatic first-pass extraction. That means a standard 5mg tablet effectively delivers about 0.75mg to the bloodstream.

The Tmax for immediate-release oral tablets averages around 50 minutes, so they need to be taken roughly an hour before sleep. Extended-release tablets mimic the gradual rise of natural nighttime melatonin secretion and are useful for sleep maintenance — but they carry a longer tail, meaning melatonin may still be active 8–10 hours later. That extended duration is associated with the morning grogginess many users report.

There is one important nuance: because tablets are so widely studied, the evidence base for their efficacy is substantial. The landmark 2013 meta-analysis of 19 RCTs involving 1,683 participants found that melatonin reduces sleep onset by 7 minutes and increases total sleep time by 8 minutes versus placebo — and that evidence base was built primarily on tablet formulations. Tablets work; they just work inefficiently, requiring higher label doses to compensate for poor absorption, which in turn increases variability and side-effect risk.

3. Gummies: Convenient But Inconsistent

Gummies are the fastest-growing melatonin category, popular with people who dislike swallowing pills and with parents seeking options for children. Their bioavailability profile is similar to tablets — both are swallowed and subject to the same first-pass metabolism — but gummies introduce a second, more serious problem: labeling accuracy. A 2023 JAMA study analyzing 25 melatonin gummy brands found that 88% were inaccurately labeled, with actual melatonin content ranging from 74% to 347% of the declared dose. One product contained no detectable melatonin.

The manufacturing challenge with gummies is that melatonin is unstable in the sugary, moist matrix used to make them. Heat, humidity, and time all degrade the active ingredient, making precise dosing much harder to maintain than in a dry tablet or capsule. The practical implication is stark: a gummy labeled "5mg" might contain anywhere from 3.7mg to 17.4mg of actual melatonin. For a supplement where physiologically effective doses start at 0.3–1mg, that kind of variance makes dose control essentially impossible. The same JAMA study concluded that clinicians should advise parents that pediatric use of melatonin gummies may result in ingestion of unpredictable quantities of melatonin — a direct consequence of the labeling inaccuracy documented across the category.

Gummies do have real advantages: palatability is high, they're easy to remember to take, and the chewing process may produce slightly faster buccal absorption than a swallowed tablet. But these advantages are outweighed for most adults by the accuracy problem. If you're trying to find your optimal melatonin dose — which requires consistency across nights — gummies are an unreliable vehicle. The labeling and quality issues that make gummies problematic are covered in detail in our melatonin safety guide. BioAbsorb Nutraceuticals takes a different approach, prioritizing third-party batch testing and verified dose accuracy over convenience-format appeal.

• Average bioavailability: ~15% (similar to tablets, possibly slightly higher due to buccal exposure)
• Onset time: 45–75 minutes
• Dose precision: Poor — 88% of brands tested were inaccurately labeled
• Best for: Users prioritizing taste and ease; not recommended where dose accuracy matters

4. Sublingual Forms: Faster Absorption, Better Bioavailability

Sublingual melatonin — tablets or sprays held under the tongue rather than swallowed — takes a different route to the bloodstream. The tissue under the tongue is richly vascularized, allowing direct absorption into the venous system and bypassing much of the first-pass hepatic metabolism that limits oral tablets. A 2023 randomized crossover study in 14 healthy volunteers found that sublingual spray produced an earlier melatonin peak and limited first-pass metabolism more effectively than a prolonged-release swallowed tablet.

The practical advantage is faster onset — sublingual forms can begin working in 15–30 minutes compared to 45–60 minutes for swallowed tablets. This matters for people who decide to take melatonin close to bedtime rather than planning an hour in advance. Bioavailability is also meaningfully higher than tablets, though the exact figure depends heavily on technique: a systematic review of alternative melatonin routes noted that oral transmucosal administration achieves higher plasma concentrations than standard oral — but this benefit evaporates if the tablet or spray is swallowed before adequate sublingual absorption can occur. Most users don't hold sublingual tablets for the full recommended time, reducing effectiveness toward tablet-level bioavailability.

Sublingual sprays have an edge over sublingual tablets here — they disperse quickly across the mucosal surface and are harder to accidentally swallow before absorption occurs. Dose flexibility is limited to half-spray or full-spray increments, making them less precise than a graduated liquid dropper. For users who want meaningfully better absorption than tablets without committing to a liposomal product, a quality sublingual spray is a reasonable intermediate step.

• Average bioavailability: Higher than tablets when used correctly; technique-dependent
• Onset time: 15–30 minutes
• Dose precision: Moderate — spray increments limited; tablet increments fixed
• Best for: Users wanting faster onset and improved absorption who prefer a spray format

5. Transdermal Patches: A Niche Use Case

Transdermal melatonin patches work similarly to nicotine patches — the melatonin is infused into an adhesive matrix applied to the skin and slowly absorbed into the bloodstream over several hours. The key pharmacokinetic difference from oral forms is the release profile: patches deliver melatonin continuously across the sleep period rather than as a single bolus. The systematic review of alternative melatonin routes found that transdermal delivery produced variable absorption rates and noted the possibility of melatonin deposition in the skin — meaning not all absorbed melatonin makes it into systemic circulation.

Where patches show genuine clinical utility is in sleep maintenance, particularly for shift workers sleeping during the day. A controlled study published in Clinical Pharmacology and Therapeutics found that transdermal melatonin increased REM sleep by 20.7 minutes and decreased wakefulness after sleep onset by 55.6 minutes in subjects sleeping during daytime hours — a significant effect. The slow, sustained release profile that makes patches less useful for sleep onset (onset can take 60–90 minutes) makes them potentially more useful for keeping melatonin active through the entire sleep opportunity.

The practical drawbacks are real: higher cost per dose, potential skin irritation, and a time-of-day absorption effect that complicates bedtime use. Patches also can't be dose-adjusted once applied. They're a specialist tool for shift workers and frequent travellers managing jet lag — not a general-purpose sleep aid.

6. Liposomal Liquid: The Bioavailability Leader

Liposomal delivery is the most significant advance in melatonin formulation technology. Our full explainer on liposomal melatonin covers the science of how this delivery mechanism works. Liposomes are microscopic phospholipid spheres — the same material that forms your cell membranes — that encapsulate the melatonin and protect it through the digestive process. Rather than exposing melatonin to stomach acid (which degrades 25–30% of a standard tablet dose) and then to first-pass liver metabolism, liposomes fuse with intestinal cell membranes to facilitate direct uptake into the lymphatic system, partially bypassing hepatic clearance. The result is substantially higher systemic availability from a lower label dose.

The bioavailability improvement is significant. Where standard tablets average 15% bioavailability, liposomal formulations achieve 80–95% bioavailability — a 4–6x improvement. That means a 1.5mg liposomal dose may deliver more melatonin to the bloodstream than a 5mg standard tablet, at one-third the label dose. This matters for two reasons: first, it makes the supplement more cost-effective per effective milligram; second, and more importantly, lower effective doses reduce the risk of the next-day grogginess and hormone disruption associated with supraphysiological melatonin exposure. The Sleep Foundation notes that doses above 5mg are no more effective than lower doses and increase side-effect risk — a finding that makes efficient absorption more valuable, not less.

Liposomal liquid also offers something no tablet, gummy, or patch can match: precise, continuous dose control. A graduated dropper allows dose adjustments of fractions of a milligram, making it the only commercially practical format for titrating toward the physiologically optimal 0.3–1mg dose range identified in research. MIT research led by Richard Wurtman found that this 0.3mg physiological dose restores sleep in older adults — a dose that is impossible to achieve from any standard tablet format but straightforward with a calibrated liquid dropper.

7. BioAbsorb Liposomal Melatonin — Precision Dosing for Real Results

BioAbsorb Liposomal Liquid Melatonin is formulated to address the core problems identified in the delivery form comparison above: poor absorption, dose inaccuracy, and inability to titrate to the physiologically effective range. At $29.99 for 100ml (100 servings), each 1ml full dropper delivers 1.5mg of melatonin via liposomal technology — achieving 80–95% bioavailability compared to the 15–20% typical of standard tablets. That's a meaningful efficiency advantage that changes what the label dose actually represents in terms of blood-level effect.

The graduated dropper is central to the product's design philosophy. Increments of approximately 0.25mg allow users to start conservatively — half a dropper at 0.75mg — and titrate up to a full dropper at 1.5mg based on their individual response. This makes it practical to work within the 0.3–1mg low-dose range that research consistently identifies as effective and safe for healthy adults. No guessing, no cutting tablets, no relying on the accuracy of a gummy that might contain 347% of its stated dose. Onset runs 15–30 minutes, meaningfully faster than tablets, which matters for people who want flexibility in their bedtime timing.

Every batch is third-party tested with COAs available on request — the quality standard that separates verified supplements from the category that produced the JAMA gummy failures. Manufactured in a GMP-certified, Health Canada-approved Canadian facility, and formulated without artificial flavours or colours. Non-GMO, vegan, gluten-free, natural mixed berry taste. For users frustrated with inconsistent tablet or gummy results, liposomal bioavailability combined with graduated dose control is a substantively different experience.

8. How to Choose the Right Melatonin Form for You

The right melatonin form depends on what problem you're trying to solve. For most adults dealing with occasional sleep onset difficulty — taking too long to fall asleep — the priority is fast onset and enough bioavailability to produce a reliable effect at a low dose. Liposomal liquid and sublingual spray both serve this use case well; tablets and gummies serve it poorly due to slow onset and unpredictable absorption. The 1,683-participant meta-analysis confirmed that melatonin reduces sleep onset by 7 minutes on average — but that average includes a lot of people who were under-absorbing from standard tablets.

For shift workers and frequent travellers who need to stay asleep during circadian-adverse conditions, the calculus is different. Extended-release tablets or transdermal patches sustain melatonin levels across a longer sleep window — useful when the goal is sleep maintenance rather than sleep initiation. The transdermal patch study showed a 55.6-minute reduction in wakefulness after sleep onset in daytime sleepers — a meaningful result for the shift worker use case specifically. The tradeoff is that patches offer no dose-adjustment flexibility and slower initial onset.

For users who have never taken melatonin before, or who want to dial in their optimal dose through careful titration, liposomal liquid is the most practical format. Starting at 0.5mg and adjusting in 0.25mg increments is only possible with a graduated dropper. It's also the format most consistent with what StatPearls and clinical guidelines recommend: the lowest effective dose, taken 30–60 minutes before the intended sleep time, without the supraphysiological loading that drives the side effects that make melatonin contentious. The form isn't a cosmetic choice — it's a clinical one.

Frequently Asked Questions

Is liquid melatonin better than tablets?

For most people, yes — but the critical variable is the delivery mechanism, not the liquid state itself. A standard liquid drop (melatonin dissolved in a carrier oil) has similar bioavailability to a tablet because it still goes through first-pass liver metabolism. Liposomal liquid achieves 80–95% bioavailability because the phospholipid encapsulation protects melatonin from digestive degradation — this is a formulation advantage, not simply a format advantage. Always check whether a liquid melatonin product is genuinely liposomal or simply melatonin dissolved in a carrier.

Why are my melatonin gummies not working?

There are two likely explanations. First, the actual melatonin content of your gummies may differ significantly from the label — the 2023 JAMA study found 88% of gummy brands were inaccurately labeled, so you may be getting considerably less (or more) than intended. Second, even at the labeled dose, gummy bioavailability is approximately 15%, meaning most of the melatonin is metabolized before it can act. Switching to a more bioavailable form at a lower label dose often produces more consistent results.

What is the most effective dose of melatonin?

Lower than most OTC products suggest. MIT research found that 0.3mg restores sleep in older adults, and the Sleep Foundation recommends starting at 0.5–1mg. The 5mg and 10mg tablets dominant in US pharmacies are physiologically excessive for most people. Higher doses don't produce proportionally better sleep and increase the risk of next-morning grogginess. The goal is the minimum effective dose — which is why a graduated dropper that allows 0.25mg increments is more useful than a fixed 5mg tablet.

How long before bed should I take melatonin?

It depends on the form. Standard oral tablets reach peak plasma concentration in approximately 50 minutes, so 45–60 minutes before bed is the typical recommendation. Liposomal liquid and sublingual sprays work faster — onset in 15–30 minutes — giving more flexibility for those who decide closer to bedtime. Extended-release tablets and transdermal patches should be applied 60–90 minutes before sleep due to slower uptake.

Can I take melatonin every night?

Current evidence suggests melatonin does not produce tolerance or dependence with continued use. The 2013 meta-analysis found effects do not dissipate over time — a meaningful distinction from prescription sleep aids. That said, most clinicians recommend the lowest effective dose and advise consulting a healthcare provider before using melatonin nightly long-term, especially if you take medications that affect hormone metabolism.

Is liposomal melatonin safe?

Liposomal delivery uses phospholipids — the same compounds that form your cell membranes — as the encapsulation material, and these are well-tolerated. The phospholipid carrier has been used in pharmaceutical drug delivery for over 40 years. StatPearls notes melatonin has a relatively benign side-effect profile compared to other sleep interventions. The key safety advantage of liposomal delivery is that it achieves effective results at lower label doses, reducing exposure to the supraphysiological amounts linked to grogginess and hormone disruption.

Conclusion

The question "what kind of melatonin is best?" comes down to one core metric: how much of the labeled dose reaches your bloodstream, and how precisely you can control that dose. Standard tablets and gummies — the most widely sold forms — average 15% bioavailability; gummies carry an 88% probability of inaccurate labeling. Sublingual forms improve on both counts but are technique-dependent. Liposomal liquid leads across all metrics: 80–95% bioavailability, 15–30 minute onset, and dose control down to 0.25mg increments. If you've been relying on tablets or gummies without consistent results, the form is the most likely explanation. BioAbsorb Liposomal Liquid Melatonin is a practical starting point: third-party tested, precision-dosed, and formulated for the bioavailability that makes a low dose actually work.

Research References

1. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS One, Vol. 8 (2013). 19 RCTs, 1,683 participants; melatonin reduces sleep onset by 7 minutes and increases total sleep time by 8 minutes vs. placebo; no tolerance observed.
2. Clinical pharmacokinetics of melatonin: a systematic review. European Journal of Clinical Pharmacology, Vol. 71 (2015). 22 pharmacokinetic studies; oral bioavailability averages 15% (range 9–33%); Tmax approximately 50 minutes for immediate-release tablets.
3. The absolute bioavailability of oral melatonin. European Journal of Clinical Pharmacology, Vol. 56 (2000). Crossover study in 12 volunteers; 2mg and 4mg oral tablets both showed ~15% absolute bioavailability due to hepatic first-pass extraction.
4. Quantity of melatonin and CBD in melatonin gummies sold in the US. JAMA, Vol. 329 (2023). 88% of 25 gummy brands inaccurately labeled; actual doses ranged 74–347% of declared quantity; one product contained no detectable melatonin.
5. Bioavailability of melatonin after oral prolonged-release tablet and sublingual spray. Drugs in R&D, Vol. 23 (2023). Sublingual spray produced an earlier melatonin peak and reduced first-pass hepatic metabolism versus swallowed prolonged-release tablet in 14 healthy volunteers.
6. Pharmacokinetics of alternative administration routes of melatonin: a systematic review. European Journal of Drug Metabolism and Pharmacokinetics, Vol. 41 (2016). Intranasal delivery offers high bioavailability; transdermal absorption is variable; sublingual achieves higher plasma concentrations than standard oral.
7. Transdermal melatonin delivery to improve sleep maintenance during daytime. Clinical Pharmacology and Therapeutics, Vol. 86 (2009). Transdermal melatonin increased REM sleep by 20.7 minutes and decreased wakefulness after sleep onset by 55.6 minutes in daytime sleep conditions.
8. Scientists pinpoint dosage of melatonin for insomnia. MIT News (2001). MIT research found 0.3mg physiological dose restores sleep in adults over 50; lower doses avoid next-day sedation.
9. Melatonin — StatPearls. NCBI Bookshelf (2024). AAFP recognizes melatonin as first-line pharmacological therapy for insomnia; AASM supports use for circadian rhythm disorders.
10. Melatonin Dosage: How Much Should You Take? Sleep Foundation (2025). Recommends starting at 0.5–1mg; 1–3mg effective for most adults; doses above 5mg no more effective and increase side-effect risk.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.